Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

In a groundbreaking achievement, an Iranian knowledge-based company has developed a new method for synthesizing Technetium (99mTc) tilmanocept, a crucial radiopharmaceutical diagnostic imaging agent. This innovative product is designed to aid in the identification of lymph nodes that may be draining from tumors, significantly impacting cancer treatment strategies.

Since 2013, the United States has stood as the sole manufacturer of this vital radiopharmaceutical agent, as reported by IRNA. The lymphatic system plays a critical role in cancer metastasis, making accurate detection of lymph node involvement essential for effective surgical intervention, particularly in patients diagnosed with breast, lung, and genital tract cancers.

Without timely identification of affected lymph nodes, surgeons may resort to removing large sections of the lymphatic system. This invasive procedure can lead to numerous side effects and severely compromise a patient’s immune system and blood circulation. The newly developed radiodiagnostic agent will assist healthcare professionals in pinpointing lymph nodes for removal, thus preserving healthy lymphatic tissue and reducing unnecessary surgeries and complications.

Thanks to this remarkable advancement, approximately 90 percent of cancer patients in Iran will have access to a more affordable and accurate diagnostic and treatment method. The drug has successfully progressed through preclinical phases and is now in the clinical trial stage.

Cancer remains one of the most pressing global health challenges, impacting millions of individuals each year. According to the Iranian Health Ministry, cancers are the leading cause of premature mortality in the country, contributing to over 55,000 deaths annually. Of these, around 34,000 deaths occur among those under 70 years, and 11,000 among those under 50 years of age, resulting from various cancer types.

The latest national cancer census indicates a concerning trend, with new cancer cases in Iran projected to rise to 160,000 by the Iranian calendar year 1404 (March 2025-March 2026), representing a 43 percent increase. The ten most common cancers in Iran include:

  • Breast Cancer
  • Prostate Cancer
  • Colon Cancer
  • Stomach Cancer
  • Lung Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Brain Cancer
  • Spinal Cancer

For Iranian women, the most prevalent cancers consist of:

  • Breast Cancer
  • Colon Cancer
  • Thyroid Cancer
  • Stomach Cancer
  • Uterine Cancer
  • Leukemia
  • Ovarian Cancer
  • Brain Cancer
  • Spinal Cancer
  • Lung Cancer
  • Esophageal Cancer

Currently, around 250,000 Iranians are living with cancer. It is noteworthy that nearly half of all cancers can be treated effectively, while the remainder can often be prevented.

Recent Achievements in Cancer Research

On January 20, 2024, the Iran University of Medical Sciences (IUMS) announced the development of an artificial intelligence (AI)-based system capable of detecting breast cancer with a remarkable 94 percent accuracy, as reported by IRNA. Breast cancer is the second leading cause of mortality among women in Iran, with approximately 30 percent of patients succumbing to the disease each year, aligning closely with the global average.

Early detection is crucial as it significantly enhances the chances of successful treatment and survival. In addition, an Iranian knowledge-based company has expressed readiness to fulfill the demand for the human papillomavirus (HPV) vaccine across regional countries and North Africa. This vaccine is essential as HPV is a known cause of cervical cancer in women.

The HPV vaccine has been produced at a substantially reduced cost, being 75 percent cheaper than foreign alternatives. Manufacturing the HPV vaccine involves one of the most intricate technologies globally, yet Iran has successfully developed this vaccine domestically. Following rigorous safety and efficacy trials, the vaccine received approval from the Food and Drug Organization in 2020.

In a notable achievement for cancer treatment, an Iranian knowledge-based company successfully produced ibrutinib, a medication used to treat various blood cancers, positioning Iran as the third country in the world capable of producing this advanced treatment. Now, Iran joins India and China as the only nations with the expertise to manufacture ibrutinib and its necessary raw materials, according to IRNA.

These advancements in cancer treatment and diagnosis signify a pivotal moment for healthcare in Iran, promising better outcomes for patients and a brighter future in the fight against cancer.

Similar Posts

  • Tehran Set to Showcase Innovation at the 13th Iran Lab Expo!

    The IRAN LAB EXPO, the 13th exhibition of Iranian-made laboratory equipment, will be held from December 13 to 16 at the Tehran Permanent International Fairgrounds. The event aims to showcase advancements in laboratory technology, reduce reliance on imports, and promote domestic production. With over 250 companies participating, the expo will feature products across 14 categories, including medical engineering, agriculture, and industrial equipment. Concurrently, Iran’s Health Minister announced efforts to attract foreign investment in the pharmaceutical sector, emphasizing Iran’s capabilities in producing generics and biopharmaceuticals, and the goal of enhancing regional collaboration for a resilient supply chain.

  • Iran’s President Pezeshkian Signals Strong Commitment to Collaboration with Muslim Nations

    President Masoud Pezeshkian expressed optimism about the potential of meetings among Muslim scholars to foster cooperation and address challenges faced by Islamic nations during the second Ministerial Meeting of the OIC-15 Dialogue Platform in Tehran. He emphasized that such gatherings create opportunities for a unified perspective among scientists. Pezeshkian highlighted the need for mutual support across sectors, collaboration in science, and encouraging joint initiatives among researchers. He noted that cooperation can elevate the status of the 1.8 billion Muslims in science and technology. Drawing on shared heritage, he concluded that synergy and collaboration can advance the Islamic world.

  • Discover Mount Sabalan: Iran’s Sacred Gravity and Majestic Natural Wonder

    Mount Sabalan, Iran’s third-highest peak at 4,811 meters, is a stunning destination in the Alborz mountain range, celebrated for its breathtaking landscapes and cultural significance. Known as Sultan Savalan, it holds spiritual importance as the site of Zoroaster’s divine revelations. The surrounding Shahsevan nomads maintain a deep connection to the mountain. Key attractions include the enchanting Crater Lake, natural hot springs, and diverse trekking terrain. Mount Sabalan also offers winter skiing at the Alvares Ski Resort. Ideal for adventure seekers, it promises a unique blend of natural beauty, cultural heritage, and thrilling activities for all explorers.

  • Iran Aims for $10 Billion Annual Trade Boost with EAEU, Says Minister

    Iran aims to increase its annual trade with the Eurasian Economic Union (EAEU) to $10 billion, up from the current $3.6 billion, as stated by Industry Minister Mohammad Atabak. This initiative focuses on strengthening economic ties and attracting investment from EAEU countries, which include Russia and Kazakhstan. Key benefits anticipated from this collaboration include enhanced scientific and technological cooperation, reduced tariffs, and improved market access. The trade expansion is expected to stimulate job creation, economic growth, and cultural exchange, contributing positively to both Iran’s economy and that of the EAEU member states amidst ongoing geopolitical challenges.

  • Tehran Celebrates National Day of Villagers and Nomads: A Vibrant Tribute to Tradition and Culture

    The National Day of Villagers and Nomads is celebrated in Tehran on October 6-7, highlighting the importance of integrated governance for rural communities. First recognized in 2013, this year’s events include conferences, exhibitions, and cultural festivals, showcasing development projects from 31 provinces aimed at improving livelihoods and alleviating rural deprivation. Vice President Zahra Behrouz-Azar emphasized the need for agricultural infrastructure, health services, and education in villages, while also urging universities to assist in rural empowerment. The day underscores the crucial role of rural communities in Iran’s economic and cultural progress, aligning with global efforts to enhance rural development and combat poverty.

  • This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly.